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Abstract
Background: Irritable bowel syndrome (IBS) is a chronic functional bowel disorder. The frequency of microscopic
colitis and focal active colitis in the colonic mucosa has been investigated in IBS patients.
Methods: Between June 2007 and September 2010, 378 patients (between 16 and 84 years) were recruited
prospectively. Of these 378 patients, 226 patients were diagnosed with IBS using the Rome III criteria. 152 control
patients were also enrolled who were undergoing colonoscopy for colorectal cancer screening or investigation of
anemia. Histopathological abnormalities identified during colonoscopy were compared between the IBS and
control groups.
Results: The average age of the IBS group was 46.13 ± 14.16 years and and the average age of the control group
was 57.01 ± 13.07 years. The prevalence of microscopic colitis (MC) in the diarrhea predominant and the mixed
subgroup of IBS patients was 4.32% (7/162) whereas in all IBS patients, the prevalence was 3.09% (7/226). MC was
not found in the 152 control cases, (p = 0.045). Lymphocytic colitis was seen in 7 IBS patients, with 1 case in the
mixed group and 6 cases in the diarrhea group and there was a significant difference in the frequency of
lymphocytic colitis between the IBS subgroups (p < 0.01). Focal active colitis was found in 6.6% (15/226) of the IBS
patients and in none of the controls (p < 0.01), and there was no differences between IBS subtypes.
Conclusion: Microscopic colitis was more often found in the diarrhea predominant/mixed subgroups of IBS
patients and in patients who were older women. In patients who are older woman with non-constipated IBS, it
may be reasonable to perform a biopsy to screen for microscopic colitis. Focal active colitis was significantly
increased in patients with IBS compared to controls.
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Background
Irritable bowel syndrome (IBS) is a functional bowel dis-
order of unknown etiology without a curative treatment.
In addition to abdominal discomfort and pain, relief
from discomfort upon defecation and/or abdominal pain
is associated with a change in the frequency of defeca-
tion and/or in the form of the feces [1]. The prevalence
of IBS varies in different populations. The prevalence of
IBS in Turkey was found 7.4-19.1% with female percen-
tage between 64% and 69% [2,3]. Similar rates have been
reported in the USA and Europe and range between
6.2% and 25% [4,5]. Although the specific location and
the pattern of symptoms varies among different func-
tional gastrointestinal diseases, there are also many com-
mon characteristics [6]. A small percentage of patients
with IBS are referred to outpatient gastroenterology
clinics.
In 1980, microscopic colitis (MC) was defined as hav-
ing symptoms of watery diarrhea and specific histologi-
cal characteristics when the colonic mucosa is
macroscopically normal or near normal [7]. Currently,
MC is divided into two subtypes- collagenous colitis
(CC) involving chronic mucosal inflammation and a
wide subepithelial band and lymphocytic colitis (LC)
involving chronic mucosal inflammation and no sube-
pithelial band. In 1976, Lindstrom showed for the first
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pithelial band in the rectum and colon in patients with
persistent watery diarrhea of unknown cause [8]. Some
experts claim that LC is an early phase of CC [9-11]. In
Europe, the annual incidence of CC is 0.6-2.3/100000
and the prevalence is 10-15.7/100000 whereas the
annual incidence of LC is 3.1/100000 and the prevalence
is 14.4/100000 [12-16]. MC and IBS have similar symp-
toms. MC not only leads to diarrhea but also causes
constipation. Constipation may be short-term or chronic
[17,18].
Focal active colitis (FAC) is characterized by focal
crypt damage caused by neutrophils and may be asso-
ciated with infections, ischemia, Crohn’sd i s e a s e ,p a r -
tially-treated ulcerative colitis and IBS [19]. It may
consist of one focus that can be detected in a single
biopsy, or multiple foci. Since focal inflammation is a
feature of Crohn’s disease, studies of FAC have exam-
ined whether it precedes the subsequent development or
diagnosis of Crohn’s disease. In two studies of adult
patients with FAC, it was observed that very few devel-
oped Crohn’s disease [19,20]. However, in a group of
pediatric patients with FAC, a higher proportion (27.6%)
went on to develop Crohn’s disease [21].
T h ep u r p o s eo ft h i ss t u d yw a st od e t e r m i n eh i s t o -
pathologically the frequency of underlying organic
causes of IBS, including MC and FAC, in macroscopi-
cally normal colonic mucosa.
Methods
Between June 2007 and September 2010, 378 patients
(between 16 and 84 years) were recruited into the study
prospectively. Two hundred and twenty six of these
patients were diagnosed with IBS using the Rome III
criteria and had no alarm symptoms, no chronic disease
history and had macroscopically normal colonoscopy/
upper gastrointestinal system endoscopic findings. There
were 152 control patients who had no history of chronic
disease or drug use, who were undergoing colonoscopy
for reasons not related to IBS (familial colorectal cancer
screening or investigation of anemia) and who had
macroscopically normal colonic mucosa.
Patients with IBS were divided into 3 subgroups
according to the Rome III criteria. Patients with hard or
lumpy stools ≥ 25% and loose (mushy) or watery stools
< 25% of bowel movements the constipation-predomi-
nant group (IBS-C). Patients with loose (mushy) or
watery stools ≥ 25% and hard or lumpy stools < 25% of
bowel movements as the diarrhea-predominant group
(IBS-D). Patients expressing hard or lumpy stools ≥ 25%
and loose (mushy) or watery stools ≥ 25% of bowel
movements were defined as the mixed group (IBS-M)
[22-24]. The presence of alarm symptoms (Table 1)[25],
malignancy of the gastrointestinal system, inflammatory
bowel disease or other chronic diseases in other systems,
metabolic or endocrine diseases (diabetes, hyperthyroid-
ism and hypothyroidism, adrenocortical diseases), heart
insufficiency, chronic obstructive pulmonary disease,
hepatic cirrhosis, chronic renal insufficiency, severe
depression or a history of persistent use of medications
and tobocco were excluded from the analysis. All
patients were examined using microscopic evaluation of
the stool, a stool occult blood test, digestive stool analy-
sis, hemogram, erythrocyte sedimentation rate, blood
glucose, urea, creatinine, liver tests, thyroid hormones
(free T4, TSH), anti-endomisium IgA and anti-gliadin
IgG antibodies with upper gastrointestinal endoscopy
(for excluding Celiac disease and other upper GIS disor-
ders), abdominal ultrasonography and colonoscopy. Dur-
ing colonoscopy, terminal ileum was intubated and then
two biopsy samples were taken from the cecum, ascend-
ing, transverse, descending, sigmoid colon and rectum.
Biopsy specimens were sent to the pathology labora-
tory in 10% formol solution. All biopsy samples were
evaluated by two pathologists who specialized in the
gastrointestinal system. Paraffin blocks were cut into 5
μm thick sections and stained with hematoxylin-eosin
(H&E) and Gomori’s trichrome stain. A diagnosis of
lymphocytic colitis required an increase in intraepithelial
lymphocytes to more than 15 lymphocytes/100 epithelial
cells, surface epithelial damage with increased lamina
propria, plasma cells and absent or minimal crypt archi-
tectural disruption. For a diagnosis of collagenous coli-
tis, an increase/irregularity in subepithelial collagen (>
10 μm) that typically trapped superficial capillaries was
required as well as the other inflammatory changes seen
in lymphocytic colitis [12]. Focal active colitis is the
term used to describe focal neutrophilic infiltration of
colonic crypts. It may consist of one focus in a single
biopsy, or multiple foci [19].
The study protocol was approved by our Institutional
(Umraniye Training and Research Hospital) Research
Ethics Committee and informed consent was obtained
from each subject.
Statistical analysis was performed using NCSS (Num-
b e rC r u n c h e rS t a t i s t i c a lS y s t e m )2 0 0 7&P A S S( P o w e r
Table 1 Alarm features considered potentially relevant in
the diagnosis of organic disease as opposed to Irritable
Bowel Syndrome
Rectal bleeding
Family history of colon cancer, inflammatory bowel disease, or celiac
disease
Night-time symptoms (awakening the patient from sleep)
Weight loss
Signs of anemia
Abdominal mass
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(Utah, USA), SPSS version 11.0 and Microsoft Excel.
Statistical comparisons of findings between the IBS and
control groups were performed by c
2 or Fisher’se x a c t
test. Logistic regression was used to adjust for differ-
ences in age and gender between groups. A p < 0.05
was considered statistically significant.
Results
A total of 378 patients were included in the study, 193
were female (51.1%), and the mean age of was 50.51 ±
14.72 for all patients (range 16-84). Two hundred and
twenty six patients were in the IBS groups and their
average age was 46.13 ± 14.16, 125 (55.3%) were female
and 101 (44.7%) were male. In the control group of 152
patients, 84 were males (55.3%), 68 were females (44.7%)
and the average age was 57.01 ± 13.07 years. There was
a statistically significant difference in the age distribu-
tions of the IBS and control groups (P < 0.01). Addition-
ally, a statistically significant difference in the gender
distribution between the two groups was present (p =
0.044). Lymphocytic colitis was present in 3.1% (7/226)
of IBS patients and 0% of controls (p < 0.05)(Table 2).
Collagenous colitis was found neither patient group, nor
control group.
The IBS group of 226 patients was divided into 3 sub-
groups. 64 patients (28.3%) were in IBS-C, 90 patients
(39.8%) were in IBS-M and 72 patients (31.9%) were in
IBS-D. Serum biochemical tests, hemoglobin values and
stool tests and macroscopic colonoscopic examinations
were normal in all patients. MC was present in 4.32%
(7/126) of non-constipated patients (diarrhea predomi-
nant and mixed) and in 3.1% of all IBS patients (7/226).
However, lymphocytic colitis differed between non-con-
stipated IBS group (IBS-D and IBS-M) and constipated
IBS patients (p < 0.01). No lymphocytic colitis was seen
in the constipation dominant group, only 1 case (1.1%)
w a ss e e ni nt h em i x e dg r o u pa n d6c a s e s( 8 . 3 % )w e r e
seen in the diarrhea dominant group (Table 3 and
Table 4).
Focal active colitis was found in 6.6% (15/226) of IBS
patients and in none of the controls (p < 0.01). There
was no significant difference among the incidence of
focal active colitis according to IBS subtype (p > 0.05),
although there was a higher incidence in the mixed
group. Of the patients with FAC, 1.6% (1/64) were in
the constipation predominant group, 11.1% (10/90) were
in the alternate group and 5.6% (4/72) were in the diar-
rhea predominant group (Table 2).
Discussion
IBS is a public health problem since it is widely seen and
does not have a cure [26]. Some experts claim that LC is a
precursor to CC [9-11]. A previously published study eval-
uated 89 patients suspected to have IBS and 59 controls
using flexible sigmoidoscopy and rectal biopsy. These
authors reported that no IBS patients or controls had
macroscopic or microscopic findings that resulted in a
change in diagnosis. Specifically, the authors identified no
patients or controls with microscopic colitis. But accord-
ing to recently published a study by Kao et al.i nw h i c ha
total of 547 cases of MC were examined, MC had a higher
occurrence in IBS than in controls (P < 0.001)[27]. Condi-
tions such as celiac disease, IBS, and thyroid disease were
found to be related to MC. Furthermore, neither an
increased risk of colorectal cancer nor IBD was associated
with MC [27]. Chey et al. found that colonoscopy and
colonic mucosal biopsies were able to identify an alterna-
tive diagnosis in 1.9% (9/466) of non-constipated IBS
patients [28]. Of these nine patients, seven had micro-
scopic colitis, one had Crohn’s disease, and one had
ulcerative colitis. The overall prevalence of microscopic
colitis was found to be 1.5% in a large cohort of non-con-
stipated IBS patients. In as u b g r o u pa n a l y s i so fI B S
patients over the age of 45, the prevalence of microscopic
colitis was 2.3% (4/171). In our study we found that all
subjects with microscopic colitis were at least 49 years old
and microscopic colitis was seen in 4.32% (7/126) of non-
constipated IBS patients and in 3.1% of all IBS patients (7/
226). All MC patients were over 45 years old and the aver-
age age was 62 ± 8. Limsui et al.f o u n dt h a t5 6 %o ft h e
131 patients diagnosed with microscopic colitis fulfilled
the Rome III criteria for IBS and that 33% had been diag-
nosed with IBS before receiving the diagnosis of micro-
scopic colitis. Therefore, patients with suspected diarrhea-
predominant IBS should undergo biopsies of the colon to
investigate possible microscopic colitis if symptoms are
not well controlled by anti-diarrheal therapy [29].
A retrospective study found that 11% (43/376) of
patients with LC and 18% (30/171) of patients with CC
had been diagnosed with IBS before receiving the diag-
nosis of MC [27]. In two large studies of patients with
MC, the mean age of diagnosis was found to be in the
seventh decade [27,29]. A recent review on this topic
suggested that between 18% and 34% of patients with
collagenous colitis may not be identified if only rectosig-
moid biopsies are obtained [30].
Table 2 Demographic and pathological data of IBS and
control patients
IBS (n = 226) Control (n = 152) p
aAge; Mean ± SD 46.13 ± 14.16 57.01 ± 1.,07 0.001**
bGender (female, %) 125 (55.3%) 68 (44.7%) 0.044*
bLymphoscytic colitis 7 (3.1%) 0 (0%) 0.045*
bFocal active colitis 15 (6.6%) 0 (0%) 0.001**
a Student t test
b c
2 test
*p < 0.05
**p < 0.01
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(constipation predominant, diarrhea predominant and
mixed). IBS can be differentiated from MC only by his-
topathological investigation. Symptoms of MC are often
attributed to diarrhea predominant IBS [31]. In view of
this information, the present study explored if mucosal
pathology, including MC, could be identified in IBS
patients using microscopic evaluation, given that macro-
scopically, the colonic mucosa was normal.
Microscopic colitis is a rare disease [12-16]. However,
Tuncer et al. reported that there is a 23.3% MC preva-
lence in IBS patients compared to a 5% prevalence in
controls [32]. According to a study by Olesen et al., MC
was diagnosed in 10% of all Swedish patients (1018
patients) with non-bloody diarrhea referred for colono-
scopy. In the subset of patients older than 70, the preva-
lence was almost 20% [14]. Another study found that
lymphocytic colitis was diagnosed in 199 cases. The
female/male ratio was 2.4:1. The median age at diagno-
sis was 59 (range: 48-70) years. The most frequent
symptoms were diarrhea (96%), abdominal pain (47%)
and weight loss (41%). The symptom course was chronic
intermittent in 30% of patients, chronic continuous in
7%, and single attack in 63%. MC patients may have
constipation and there may be an association between
MC and chronic constipation. Chronic constipation was
found in 43.39% of MC patients in the study performed
by Barta et al. [17,26]. However, in our study, MC was
not found in the constipation predominant IBS sub-
group. According to the American College of Gastroen-
terology Task Force [25], “routine colonic imaging is
not recommended in patients younger than 50 years of
age with typical IBS symptoms and no alarm features.
When colonoscopy is performed in patients with IBS-D,
obtaining random biopsies should be considered to rule
out microscopic colitis.”
Focal active colitis is characterized by focal crypt
damage caused by neutrophils and may be associated
with infections, ischemia, Crohn’s disease, partially-trea-
ted ulcerative colitis and IBS [19]. There are reports that
there is an association between focal active colitis and
oral sodium phosphate ingestion [33-36]. Driman et al.
indicated that evidence is emerging that sodium phos-
phate is a commonly used oral laxative agent, causes
aphthoid ulcers and/or FAC in the colon and rectum.
FAC was present in 11 of 316 patients (3.5%) who had
biopsies but who were otherwise normal, as determined
by endoscopic evaluation [33]. In a follow-up study by
Xin et al., which consisted of 29 patients who were
diagnosed with focal active colitis, the disease duration
ranged from 4 months to 7 years with a mean of 4.2
years. Eight patients (27.6%) developed Crohn’s disease.
Pediatric patients with focal active colitis have a much
higher incidence of Crohn’s disease than adults. Hence,
Table 3 Demographic and pathological data of IBS subgroups
IBS subgroups p
IBS-C (n = 64) IBS-M (n = 90) IBS-D (n = 72)
aAge (Mean ± SD) 43.54 ± 13.17 47.53 ± 13.54 46.68 ± 15.57 0.211
bGender (female,%) 43 (67.2%) 45 (50%) 37 (51.4%) 0.077
bLymphochytic colitis n (%) 0 (0%) 1 (1.1%) 6 (8.3%) 0.007**
bFocal active colitis n (%) 1 (1.6%) 10 (11.1%) 4 (5.6%) 0.058
a Oneway Anova test
b c
2 test or Fisher’s exact test
**p < 0.01
Table 4 Demografic characteristics of patients with
lymphocytic colitis and focal active colitis
Age Gender IBS Subtype
Lymphocytic colitis (Mean age: 60.5)
Patient 1 49 Female IBS-D
Patient 2 49 Female IBS-M
Patient 3 56 Female IBS-D
Patient 4 56 Female IBS-D
Patient 5 69 Female IBS-D
Patient 6 70 Female IBS-D
Patient 7 75 Female IBS-D
Focal active colitis (Mean age: 45.7)
Patient 1 21 Male IBS-D
Patient 2 24 Male IBS-M
Patient 3 30 Female IBS-D
Patient 4 31 Female IBS-M
Patient 5 32 Male IBS-M
Patient 6 49 Male IBS-M
Patient 7 50 Male IBS-D
Patient 8 50 Female IBS-M
Patient 9 51 Female IBS-M
Patient 10 54 Male IBS-M
Patient 11 54 Female IBS-M
Patient 12 54 Male IBS-M
Patient 13 60 Female IBS-C
Patient 14 60 Male IBS-M
Patient 15 66 Female IBS-D
IBS-C: Constipated predominant, IBS-D: Diarrhea predominant, IBS-M:Mixed
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colitis in pediatric patients [21]. In this study we found
that 6.6% of IBS patients had focal active colitis (15/226)
and this ratio is higher than that reported in previous
s t u d i e s .I tm a yb ee l i g i b l et a k ear o u t i n eb i o p s yi n
female patients and in patients over 50 years old.
We acknowledge the limitation of the study is the dif-
ference between the groups in terms of age and gender.
The percentage of women with IBS is 55.3%. This per-
centage is close to the female:male ratio of previous stu-
dies from Turkey. The mean age of the control group
was higher than the IBS patients. However, this situation
was due to selection of asymptomatic patients screened
for colorectal cancer and anemia.
Conclusion
Microscopic colitis can be identified in patients with
diarrhea predominant IBS and in women of older age
with IBS. It appears reasonable to test for microscopic
colitis in those patients by performing a colonic biopsy.
Focal active colitis was found to be more common than
expected. Routine biopsy of normal colonic mucosa
helps identify rare miscellaneous causes of colitis.
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